Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Influence of inhaled procaterol on pulmonary rehabilitation in chronic obstructive pulmonary disease.

Hasegawa M, Dobashi K, Horie T, Wada N, Shirakura K.

Respir Investig. 2012 Dec;50(4):135-9. doi: 10.1016/j.resinv.2012.08.003. Epub 2012 Sep 13.

PMID:
23199977
2.

[Effect of proactive use of inhaled procaterol on dyspnea in daily activities and quality of life in patients with chronic obstructive pulmonary disease].

Satoh H, Iwashima A, Endo Y, Nakayama H, Hasegawa T, Suzuki E.

Nihon Kokyuki Gakkai Zasshi. 2009 Sep;47(9):772-80. Japanese.

PMID:
19827580
4.

Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD.

Sukisaki T, Senjyu H, Oishi K, Rikitomi N, Ariyoshi K.

Physiother Theory Pract. 2008 Jul-Aug;24(4):255-63. doi: 10.1080/09593980701686815.

PMID:
18574751
5.

Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.

Mochizuki H, Nanjo Y, Takahashi H.

Geriatr Gerontol Int. 2013 Apr;13(2):398-404. doi: 10.1111/j.1447-0594.2012.00916.x. Epub 2012 Jul 23.

PMID:
22817699
6.

Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.

Berton DC, Silveira L, Da Costa CC, De Souza RM, Winter CD, Zimermann Teixeira PJ.

Arch Phys Med Rehabil. 2013 Aug;94(8):1607-14. doi: 10.1016/j.apmr.2013.02.005. Epub 2013 Feb 14.

PMID:
23416765
7.

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S; Tiotropium Multicentric Italian Study Group.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):771-80.

9.
10.

Effectiveness of home-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.

Liu XL, Tan JY, Wang T, Zhang Q, Zhang M, Yao LQ, Chen JX.

Rehabil Nurs. 2014 Jan-Feb;39(1):36-59. doi: 10.1002/rnj.112. Epub 2013 Jun 18.

PMID:
23780865
11.

A randomised study of the effects of supplemental exercise sessions after a 7-week chronic obstructive pulmonary disease rehabilitation program.

Linneberg A, Rasmussen M, Buch TF, Wester A, Malm L, Fannikke G, Vest S.

Clin Respir J. 2012 Apr;6(2):112-9. doi: 10.1111/j.1752-699X.2011.00256.x. Epub 2011 Jul 6.

PMID:
21651747
12.

Home-based pulmonary rehabilitation in very severe COPD: is it safe and useful?

Fernández AM, Pascual J, Ferrando C, Arnal A, Vergara I, Sevila V.

J Cardiopulm Rehabil Prev. 2009 Sep-Oct;29(5):325-31. doi: 10.1097/HCR.0b013e3181ac7b9d.

PMID:
19561524
13.

Effects of home-based pulmonary rehabilitation with a metronome-guided walking pace in chronic obstructive pulmonary disease.

Lee SS, Kim C, Jin YS, Oh YM, Lee SD, Yang YJ, Park YB.

J Korean Med Sci. 2013 May;28(5):738-43. doi: 10.3346/jkms.2013.28.5.738. Epub 2013 May 2.

14.

The impact of dyspnoea and leg fatigue during exercise on health-related quality of life in patients with COPD.

Katsura H, Yamada K, Wakabayashi R, Kida K.

Respirology. 2005 Sep;10(4):485-90.

PMID:
16135172
16.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

PMID:
22161409
17.

[Home-based exercise training in chronic obstructive pulmonary disease].

Milenković B, Zizić-Borjanović S, Borjanović S, Rebić P.

Srp Arh Celok Lek. 2007 Jul-Aug;135(7-8):419-24. Serbian.

18.

Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease.

Satake M, Takahashi H, Sugawara K, Kawagoshi A, Tamaki A, Homma M, Morita R, Sato K, Sano M, Shioya T.

Arzneimittelforschung. 2011;61(1):8-13. doi: 10.1055/s-0031-1296162.

PMID:
21355441
19.

Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD.

Ohbayashi H, Adachi M.

Int J Gen Med. 2012;5:517-24. doi: 10.2147/IJGM.S20833. Epub 2012 Jun 15.

20.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759

Supplemental Content

Support Center